1 王宇,郑世民.白细胞介素-8及其在动物疾病发生中的作用[J].中国畜牧兽医,2010,37(3):198~201. 2 王海鹰.艰难梭菌葡萄糖基转移酶基因突变毒素及其在疫苗应用中的研究[D].广州:华南理工大学,2011. 3 尹业师,王欣.人艰难梭菌感染的致病机制与防治策略研究进展[J].现代生物医学进展,2013,13(26):5155~5160. 4 许方方,胡玉苗,冉珊珊,等.艰难梭菌毒素及致病基因的研究进展[J].动物医学进展,2013,34(7):100~103. 5 李先平,李文革,王晶,等.中美艰难梭菌A-B+株毒力编码区域转录及B毒素表达的研究[J].中国感染控制杂志,2014,13(2):65~70. 6 苏文金.肠道菌群对艰难梭菌拮抗作用的动物模型研究[J].厦门大学学报自然科学版,1988,27(5):578~582. 7 张建华,宋铁牛,李斌,等.艰难梭菌A毒素对食管癌干细胞损伤的研究[J].中国现代医学杂志,2013,25:16~19. 8 杨雪妹,吴允孚.艰难梭菌的生物学特性与实验室诊断[J].中国感染与化疗杂志,2013a,13(3):232~234. 9 杨雪妹,吴允孚.艰难梭菌感染的流行病学和诊治进展[J].中国感染与化疗杂志,2013b,13(4):312~316. 10 曹波,李先平,程颖.艰难梭菌引起抗感染免疫的主要致病因子及其基因功能的研究进展[J].免疫学杂志,2013,29(4):357~360. 11 章黎华,董丹凤,江岑,等.院内感染艰难梭菌的毒素检测及核糖体分型研究[J].上海交通大学学报(医学版),2012,32(11):1436~1440. 12 程慧,李芳.IL-8与结直肠癌[J].大连医科大学学报,2014,36(1):95~97. 13 董妍玲,潘学武.细菌S-layer 蛋白的研究新进展[J].化学与生物工程,2010,27(2):11~14. 14 傅思武,毛敏燕,苏露,等.艰难梭菌B毒素的纯化及其生物学特性[J].中国生物制品学杂志,2011,24(10):1217~1220. 15 薛超辉,张兰威,王淑梅,等.益生菌预防与治疗艰难梭菌腹泻的研究进展[J].食品工业科技,2013,22:358~362. 16 Bishop A L,Hall A.Rho GTPases and their effector proteins[J].Biochem,2000,348(2):241~255. 17 Burridge K,Wennerberg K.Rho and Rac take center stage[J].Cell,2004,116:167~179. 18 Davies N L,Compson J E,Mackenzie B,et al.A mixture of functionally oligoclonal humanized monoclonal antibodies that neutralize Clostridium difficile TcdA and TcdB with high levels of in vitro potency shows in vivo protection in a hamster infection model[J].Clinical and Vaccine Immunology,2013,20(3):377~390. 19 Dineen S S,Villapakkam A C,Nordman J T,et al.Repression of Clostridium difficile toxin gene expression by CodY[J].Mol Microbilo,2007,66:206~219. 20 Donta S T,Sullivan N,Wilkins T D.Differential effects of Clostridium difficile toxins on tissuecultured cells[J].Clin Microbiol,1982,15:1157~1158. 21 Dupuy B,Govind R,Antunes A,et al.Clostridium difficile toxin synthesis is negatively regulated by TcdC[J].Journal of Medical Microbiology,2008,57:685~689. 22 Geric B,Carman R J,Rupnik M,et al.Binary toxin-producing,large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters[J].J Infect Dis,2006,193:1143~1150. 23 Govind R,Dupuy B.Secretion of Clostridium difficile toxins A and B requires the Holin like protein TcdE[J].PLoS Pathogens,2012,8(6):1~14. 24 Hundsberger T,Braun V,Weidmann M,et al.Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile[J].Eur J Biochem,1997,244(3):735~742. 25 Johnson S,Samore M H,Farrow K A,et al.Epidemics of diarrhea cause by a clindamycin-resistant strain of Clostridium difficile in four hospitals[J].N Engl J Med,1999,341(22):1645~1651. 26 Kelly C P,Becker S,Linevsky J K,et al.Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit[J].Journal of Clinical Investigation,1994,93:1257~1265. 27 Kolling G L, Wu M, Warren C A,et al.Lactic acid production by Streptococcus thermophilus alters Clostridium difficile infection and in vitro toxin A production[J].Gut Microbes,2012,3(6):523~529. 28 Koon H W,Shih D Q,Hing T C,et al.Human monoclonal antibodies against Clostridium difficile toxins A and B inhibit inflammatory and histologic responses to the toxins in human colon and peripheral blood monocytes[J].Antimicrobial Agents and Chemotherapy,2013,58(7):3124~3133. 29 Kuehne S A,Cartman S T,Heap J T,et al.The role of toxin A and toxin B in Clostridium difficile infection[J].Nature,2010,467:711~714. 30 Lyras D,O'Connor J R,Howarth P M,et al.Toxin B is essential for virulence of Clostridium difficile[J].Nature,2009,458(7242):1176~1179. 31 Pruitt R N,Lacy D B.Toward a structural understanding of Clostridium difficile toxins A and B[J].Cellular and Infection Microbiology,2012,2(28):1~14. 32 Riegler M,Sedivy R,Pothoulaki C,et al.Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro[J].Clin Invest,1995,95:2004~2011. 33 Santos A A,Braqa-Neto M B,Oliveira M R,et al.Glutamineand alanyl-glutamine increase RhoA expression and reduce Clostridium difficile toxin-A-induced intestinal epithelial cell damage[J].Bio Med Research International,2012,2013:1~13. 34 Spigaglia P,Mastrantonio P.Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates[J].American Society for Microbiology,2002,40(9):3470~3475. 35 Steele J,muherjee J,Parry N,et al.Antibody against TcdB,but not TcdA,prevents development of gastrointestinal and systemic Clostridium difficile disease[J].The Journal of Infectious Diseases,2013,207:323~331. 36 Warren C A,Calabress G M,Li Y,et al.Effects of adenosine A2A receptor activation and alanyl-glutamine in Clostridium difficile toxin-induced ileitis in rabbits and cecitis in mice[J].BMC Infectious Diseases,2012,12:13. 37 Wullt M,Norén T,Ljungh A,et al.IgG antibody response to toxins A and B in patients with Clostridium difficile infection[J].Clinical and Vaccine Immunology,2012,19(9):1552~1554. |